{
  "Fetal_Liver_Gel_Velos_24_f07.raw": {
    "Source Name": [
      "Fetal_Liver"
    ],
    "Assay Name": [
      "Fetal_Liver_f07"
    ],
    "Raw Data File": [
      "Fetal_Liver_Gel_Velos_24_f07.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Fetal_Liver"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Velos"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f07"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Adult_Kidney_Gel_Velos_9_f09.raw": {
    "Source Name": [
      "Adult_Kidney"
    ],
    "Assay Name": [
      "Adult_Kidney_f09"
    ],
    "Raw Data File": [
      "Adult_Kidney_Gel_Velos_9_f09.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Adult_Kidney"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Velos"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f09"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Adult_NKcells_Gel_Elite_78_f13.raw": {
    "Source Name": [
      "Adult_NKcells"
    ],
    "Assay Name": [
      "Adult_NKcells_f13"
    ],
    "Raw Data File": [
      "Adult_NKcells_Gel_Elite_78_f13.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Adult_NKcells"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Elite"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f13"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Fetal_Brain_Gel_Velos_16_f21.raw": {
    "Source Name": [
      "Fetal_Brain"
    ],
    "Assay Name": [
      "Fetal_Brain_f21"
    ],
    "Raw Data File": [
      "Fetal_Brain_Gel_Velos_16_f21.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Fetal_Brain"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Velos"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f21"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Adult_Platelets_Gel_Velos_36_f36.raw": {
    "Source Name": [
      "Adult_Platelets"
    ],
    "Assay Name": [
      "Adult_Platelets_f36"
    ],
    "Raw Data File": [
      "Adult_Platelets_Gel_Velos_36_f36.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Adult_Platelets"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Velos"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f36"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Adult_Liver_Gel_Elite_83_f16.raw": {
    "Source Name": [
      "Adult_Liver"
    ],
    "Assay Name": [
      "Adult_Liver_f16"
    ],
    "Raw Data File": [
      "Adult_Liver_Gel_Elite_83_f16.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Adult_Liver"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Elite"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f16"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Adult_Liver_Gel_Velos_11_f26.raw": {
    "Source Name": [
      "Adult_Liver"
    ],
    "Assay Name": [
      "Adult_Liver_f26"
    ],
    "Raw Data File": [
      "Adult_Liver_Gel_Velos_11_f26.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Adult_Liver"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Velos"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f26"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Fetal_Heart_Gel_Velos_21_f24.raw": {
    "Source Name": [
      "Fetal_Heart"
    ],
    "Assay Name": [
      "Fetal_Heart_f24"
    ],
    "Raw Data File": [
      "Fetal_Heart_Gel_Velos_21_f24.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Fetal_Heart"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Velos"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "SDS-PAGE"
    ],
    "Comment[FractionIdentifier]": [
      "f24"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Fetal_Ovary_bRP_Velos_41_f15.raw": {
    "Source Name": [
      "Fetal_Ovary"
    ],
    "Assay Name": [
      "Fetal_Ovary_f15"
    ],
    "Raw Data File": [
      "Fetal_Ovary_bRP_Velos_41_f15.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Fetal_Ovary"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Velos"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "bRPLC"
    ],
    "Comment[FractionIdentifier]": [
      "f15"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  },
  "Adult_CD4Tcells_bRP_Elite_28_f08.raw": {
    "Source Name": [
      "Adult_CD4Tcells"
    ],
    "Assay Name": [
      "Adult_CD4Tcells_f08"
    ],
    "Raw Data File": [
      "Adult_CD4Tcells_bRP_Elite_28_f08.raw"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "histologically normal human tissues and cells"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "IAA"
    ],
    "Characteristics[Modification]": [
      "carbamidomethylation of cysteine"
    ],
    "Characteristics[NumberOfSamples]": [
      "30 histologically normal tissues and cells"
    ],
    "FactorValue[Experimental]": [
      "Adult_CD4Tcells"
    ],
    "Comment[Instrument]": [
      "LTQ-Orbitrap Elite"
    ],
    "Comment[AcquisitionMethod]": [
      "Data-dependent acquisition"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collision dissociation (HCD)"
    ],
    "Comment[CollisionEnergy]": [
      "35% normalized collision energy"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap mass analyzer"
    ],
    "Comment[FlowRateChromatogram]": [
      "a flow rate of 350 nL/min"
    ],
    "Comment[GradientTime]": [
      "over 60 min"
    ],
    "Comment[FractionationMethod]": [
      "bRPLC"
    ],
    "Comment[FractionIdentifier]": [
      "f08"
    ],
    "Comment[NumberOfFractions]": [
      "concatenated to 24 fractions"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.05 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages allowed"
    ],
    "Comment[Separation]": [
      "Easy-nLC II nanoflow liquid chromatography system"
    ]
  }
}